New Drugs, Regimens, and Strategies for Multiple Myeloma: Case Studies for Nurses (https://www.myeloma.org/publications-videos/healthcare-professional-resources/new-drugs-regimens-strategies-multiple-myeloma)
New Drugs, Regimens, and Strategies for Multiple Myeloma: Case Studies for Nurses
The following videos, presented by Medscape Oncology, are designed for healthcare practitioners to earn continuing education (CE) credits.
In this CE program, nurses from the IMF's Nurse Leadership Board (NLB) present new drugs, regimens, and strategies for multiple myeloma.
1. Register for free at Medscape.org (https://www.Medscape.org)
2. Login to your Medscape account.
3. Select the course sections below.
4. View this virtual course in its entirety.
5. Complete 1.50 ANCC Contact Hour(s) credit activities.
Note: These CE credits are valid through December 30, 2022.
IMF Nurse Leadership Board nurses Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN (Taussig Cancer Institute—Cleveland, Ohio), Donna D. Catamero, ANP-BC, OCN, CCRC (The Mount Sinai Health System—New York, NY), and Kim Noonan, DNP, RN, ANP-BC, AOCN® (Dana-Farber Cancer Institute—Boston, MA) discuss new drugs, regimens, and strategies for multiple myeloma.
Upon completion of this activity, participants should be better able to:
Discuss treatment regimens for patients with newly diagnosed or relapsed multiple myeloma including appropriate symptom management and patient education
Identify healthcare disparities faced by patients with multiple myeloma who are part of minority groups and strategies to overcome these
Describe strategies to support the patient’s input in therapeutic decisions
Supported by independent grants from:
The Annenberg Center for Health Sciences at Eisenhower and International Myeloma Foundation
Amgen, Abbvie, Bristol Myers Squibb, Janssen Biotech, Karyopharm Therapeutics, Pfizer, GSK, and Takeda Pharmaceuticals